GB1327870A - Process for the manufacture of a vaccine against infectious bursitis of chickens - Google Patents

Process for the manufacture of a vaccine against infectious bursitis of chickens

Info

Publication number
GB1327870A
GB1327870A GB4255271A GB4255271A GB1327870A GB 1327870 A GB1327870 A GB 1327870A GB 4255271 A GB4255271 A GB 4255271A GB 4255271 A GB4255271 A GB 4255271A GB 1327870 A GB1327870 A GB 1327870A
Authority
GB
United Kingdom
Prior art keywords
virus
mice
bursitis
vaccine
mouse
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4255271A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of GB1327870A publication Critical patent/GB1327870A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB4255271A 1970-09-12 1971-09-13 Process for the manufacture of a vaccine against infectious bursitis of chickens Expired GB1327870A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2045160A DE2045160C3 (de) 1970-09-12 1970-09-12 Verfahren zur Herstellung einer Lebendvaccine gegen die infektiöse Bursitis der Hühner

Publications (1)

Publication Number Publication Date
GB1327870A true GB1327870A (en) 1973-08-22

Family

ID=5782254

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4255271A Expired GB1327870A (en) 1970-09-12 1971-09-13 Process for the manufacture of a vaccine against infectious bursitis of chickens

Country Status (11)

Country Link
US (1) US3769400A (enExample)
AT (1) AT308967B (enExample)
BE (1) BE772448A (enExample)
CH (1) CH560760A5 (enExample)
DE (1) DE2045160C3 (enExample)
DK (1) DK129590B (enExample)
ES (1) ES394860A1 (enExample)
FR (1) FR2106482B1 (enExample)
GB (1) GB1327870A (enExample)
IL (1) IL37682A (enExample)
NL (1) NL150684B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530831A (en) * 1982-11-02 1985-07-23 Akzo N.V. Infectious Bursal Disease vaccine
JPS61500663A (ja) * 1983-12-13 1986-04-10 コモンウエルス　サイエンテイフイツク　アンド　インダストリアル　リサ−チ　オ−ガナイゼイシヨン 感染性嚢病ウィルスワクチン
HU197846B (en) * 1984-07-02 1989-06-28 Laszlo Csatary Process for producing therapeutic composition suitable for treating virus infections
US4824668A (en) * 1987-03-09 1989-04-25 Sterwin Laboratories Inc. Attenuated infectious bursal disease virus strain and vaccine therefrom
US5192539A (en) * 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines

Also Published As

Publication number Publication date
NL150684B (nl) 1976-09-15
NL7112237A (enExample) 1972-03-14
DK129590B (da) 1974-10-28
AT308967B (de) 1973-07-25
FR2106482B1 (enExample) 1974-10-18
DE2045160A1 (de) 1972-03-30
FR2106482A1 (enExample) 1972-05-05
CH560760A5 (enExample) 1975-04-15
DE2045160C3 (de) 1975-04-10
DK129590C (enExample) 1975-03-24
BE772448A (fr) 1972-03-10
ES394860A1 (es) 1975-01-01
IL37682A0 (en) 1971-11-29
US3769400A (en) 1973-10-30
DE2045160B2 (de) 1974-08-22
IL37682A (en) 1974-06-30

Similar Documents

Publication Publication Date Title
Brown et al. Application of agar-gel diffusion analysis to a study of the antigenic structure of inactivated vaccines prepared from the virus of foot-and-mouth disease
GB1183506A (en) New vaccines for combating influenza and the preparation thereof
GB1327870A (en) Process for the manufacture of a vaccine against infectious bursitis of chickens
US4191745A (en) Preparation for the treatment of Herpes zoster and other Herpes infections, as well as method for manufacture thereof
ES373631A1 (es) Procedimiento para la obtencion de una vacuna activa contrala enfermedad de maret.
GB1590448A (en) Vaccine and its preparations
HU211896A9 (en) Chicken anaemia agent vaccine
Gelb et al. Studies on interferon induction by infectious bursal disease virus (IBDV). II. Interferon production in White Leghorn chickens infected with an attenuated or pathogenic isolant of IBDV
Cook et al. Attenuation of turkey rhinotracheitis virus by alternative passage in embryonated chicken eggs and tracheal organ cultures
JPS6225127B2 (enExample)
KR940010022B1 (ko) 닭의 전염병(전염성 후두기관염 및 마렉크 병)생 왁진
Frazier Ultrastructure of lymphoid tissue from chicks infected with Marek's disease virus
US10124057B2 (en) Method of quickly producing antibodies against avian influenza and maintain antibody titer of duck
Estupinan et al. Methods of isolating six mutant classes from the Hickman strain of Newcastle disease virus
JP2655726B2 (ja) ニューカッスル病ウイルス生ワクチン
EP0292210A2 (en) Attenuated virus and vaccine therefrom for use against infections in fowl caused by Turkey rhinotracheitis virus
Van der Zijpp et al. The immune response of the chick following viral vaccinations and immunization with sheep red blood cells
JPH01272529A (ja) 混合生ワクチン
Blakemore Further observations on the demonstration of an infective agent in the tissues of fowls affected with fowl paralysis (neurolymphomatosis)
JPH0571226B2 (enExample)
US2445300A (en) Virus vaccines
Eidson et al. Resistance of progeny from parental stock of chickens immunized against Marek's disease
Eidson et al. Maternal transfer of resistance against development of Marek's disease tumors
Kempf et al. Hypotensive Action of Influenza A Virus on Rats.
MEASLES By SD Sj_GREVAL

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee